MLYS | Mineralys Therapeutics, Inc. Annual & Quarterly

Annual Income Statements

(In USD)

Breakdown	2023	2022	2021	2020
Revenue	-	-	-	-
Cost of Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Expenses	84.65 Million	31.47 Million	18.72 Million	2.94 Million
Selling, General and Administrative Expenses	14.29 Million	5.22 Million	2.41 Million	532 Thousand
Research and Development Expenses	70.36 Million	26.25 Million	16.3 Million	2.41 Million
Other Expenses	-	4000.00	1000.00	-1000.00
Cost and Expenses	84.65 Million	31.47 Million	18.72 Million	2.94 Million
Operating Income	-84.65 Million	-31.47 Million	-18.72 Million	-2.94 Million
Interest Expense	-	1.67 Million	27 Thousand	115 Thousand
Income Tax Expense	-	-1.9 Million	27 Thousand	115 Thousand
Earnings before Tax	-71.89 Million	-29.79 Million	-19.4 Million	-3.42 Million
Net Income	-71.89 Million	-29.79 Million	-19.4 Million	-3.42 Million
Earnings Per Share Basic	-1.99	-0.73	-0.50	-0.09
Earnings Per Share Diluted	-1.99	-0.73	-0.50	-0.09
Weighted Average Shares Outstanding	36.18 Million	40.85 Million	39.05 Million	39.05 Million
Weighted Average Shares Outstanding (Diluted)	36.18 Million	40.85 Million	39.05 Million	39.05 Million
Gross Margin	-	-	-	-
EBIT Margin	-	-	-	-
Profit Margin	-	-	-	-
EBITDA	-84.65 Million	-31.47 Million	-	-
Earnings Before Tax Margin	-	-	-	-

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Revenue	-	-	-	-	-	-
Cost of Revenue	9000.00	8000.00	-	-	-	-
Gross Profit	-9000.00	-8000.00	-	-	-	-
Operating Expenses	45.15 Million	35.35 Million	84.65 Million	27.71 Million	26.27 Million	15.73 Million
Selling, General and Administrative Expenses	5.88 Million	4.6 Million	-	4.02 Million	3.77 Million	3.85 Million
Research and Development Expenses	39.27 Million	30.75 Million	-	23.68 Million	22.49 Million	11.88 Million
Other Expenses	2000.00	1000.00	-	1000.00	-	1000.00
Cost and Expenses	45.16 Million	35.36 Million	84.65 Million	27.71 Million	26.27 Million	15.73 Million
Operating Income	-45.16 Million	-35.36 Million	-84.65 Million	-27.71 Million	-26.27 Million	-15.73 Million
Interest Expense	-	-	-	-	-	-
Income Tax Expense	-	-35.27 Thousand	-167.89 Thousand	-43.81 Thousand	39.58 Thousand	-3.71 Million
Earnings before Tax	-41.01 Million	-31.5 Million	-71.89 Million	-24.38 Million	-22.76 Million	-12.14 Million
Net Income	-41.01 Million	-31.5 Million	-71.89 Million	-24.38 Million	-22.76 Million	-12.14 Million
Earnings Per Share Basic	-0.83	-0.70	-	-0.61	-0.55	-0.30
Earnings Per Share Diluted	-0.83	-0.70	-	-0.61	-0.55	-0.30
Weighted Average Shares Outstanding	49.35 Million	44.9 Million	36.18 Million	40.09 Million	41.1 Million	40.85 Million
Weighted Average Shares Outstanding (Diluted)	49.35 Million	44.9 Million	36.18 Million	40.09 Million	41.1 Million	40.85 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-45.15 Million	-35.35 Million	-	-27.71 Million	-26.27 Million	-15.73 Million
Earnings Before Tax Margin	-	-	-	-	-	-